Further integrated bioinformatics and meta-analysis of multi-omics data and clinical evidence points to interconnected inflammatory and immune dysfunction centered around AKT1, IL-6, and TNF as key mechanisms linking obesity to elevated gastric cancer risk. The gene discussed is AKT1; the disease is obesity due to melanocortin 4 receptor deficiency.